Surgalign Holdings, Inc. – NASDAQ:SRGA

Financial Health
0
1
2
3
4
5
6
7
8
9

Surgalign Holdings stock price monthly change

-75.08%
month

Surgalign Holdings stock price quarterly change

-85.99%
quarter

Surgalign Holdings stock price yearly change

-93.77%
year

Surgalign Holdings key metrics

Market Cap
N/A
Enterprise value
2.28M
P/E
-0.17
EV/Sales
0.01
EV/EBITDA
-0.04
Price/Sales
0.06
Price/Book
-0.32
PEG ratio
N/A
EPS
-7.58
Revenue
78.12M
EBITDA
-66.40M
Income
-50.48M
Revenue Q/Q
-18.71%
Revenue Y/Y
-11.03%
Profit margin
-48.91%
Oper. margin
-56.18%
Gross margin
55.75%
EBIT margin
-56.18%
EBITDA margin
-85.01%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Surgalign Holdings stock price history

Surgalign Holdings stock forecast

Surgalign Holdings financial statements

Surgalign Holdings, Inc. (NASDAQ:SRGA): Profit margin
Jun 2022 20.62M -5.68M -27.58%
Sep 2022 20.17M -9.83M -48.73%
Dec 2022 20.57M -39.11M -190.11%
Mar 2023 16.74M 4.14M 24.75%
Surgalign Holdings, Inc. (NASDAQ:SRGA): Earnings per share (EPS)
2023-08-08 0.27 -2.05
Surgalign Holdings, Inc. (NASDAQ:SRGA): Debt to assets
Jun 2022 105697000 84.86M 80.29%
Sep 2022 88043000 75.66M 85.94%
Dec 2022 70242000 95.97M 136.63%
Mar 2023 67712000 86.64M 127.96%
Surgalign Holdings, Inc. (NASDAQ:SRGA): Cash Flow
Jun 2022 -13.27M -1.87M 135K
Sep 2022 -13.37M -2.32M -7K
Dec 2022 -6.32M -1.71M 10.88M
Mar 2023 -9.02M 15.66M -19K

Surgalign Holdings alternative data

Surgalign Holdings, Inc. (NASDAQ:SRGA): Employee count
Aug 2023 217
Sep 2023 217
Oct 2023 217
Nov 2023 217
Dec 2023 217
Jan 2024 217
Feb 2024 217
Mar 2024 217
Apr 2024 217
May 2024 217
Jun 2024 217
Jul 2024 217

Surgalign Holdings other data

10.53% -16.55%
of SRGA is owned by hedge funds
690.17K -1.13M
shares is hold by hedge funds

Surgalign Holdings, Inc. (NASDAQ:SRGA): Insider trades (number of shares)
Period Buy Sel
Aug 2021 450745 0
Feb 2022 1238806 0
May 2022 19000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LYLE DAVID officer: Chief Financial Officer
Common Stock 19,000 $5.26 $99,921
Purchase
THUNANDER CHRISTOPHER officer: Chief Accounting Officer
Warrants (right to buy) 97,500 $0.6 $58,500
Purchase
RICH TERRY M. director, officer.. Warrants (right to buy) 326,088 $0.6 $195,653
Purchase
RICH TERRY M. director, officer.. Common Stock 434,784 $0.46 $200,001
Purchase
DURALL WILLIAM SCOTT officer: Chief Co.. Warrant (right to buy) 163,043 $0.6 $97,826
Purchase
DURALL WILLIAM SCOTT officer: Chief Co.. Common Stock 217,391 $0.46 $100,000
Purchase
MCEACHIN THOMAS director
Common Stock 20,000 $1.03 $20,600
Purchase
RICH TERRY M. director, officer.. Common Stock 10,100 $0.91 $9,191
Purchase
VALERIANI NICHOLAS J director
Common Stock 55,000 $0.95 $52,250
Purchase
RICH TERRY M. director, officer.. Common Stock 365,645 $0.94 $343,706
Tuesday, 27 June 2023
InvestorPlace
Monday, 26 June 2023
InvestorPlace
Tuesday, 20 June 2023
InvestorPlace
Monday, 5 June 2023
Zacks Investment Research
Thursday, 11 May 2023
Seeking Alpha
Zacks Investment Research
Thursday, 4 May 2023
GlobeNewsWire
Thursday, 30 March 2023
Seeking Alpha
Tuesday, 21 March 2023
GlobeNewsWire
Wednesday, 2 November 2022
Seeking Alpha
Tuesday, 25 October 2022
GlobeNewsWire
Tuesday, 9 August 2022
Seeking Alpha
Monday, 16 May 2022
Benzinga
Tuesday, 10 May 2022
Seeking Alpha
Tuesday, 15 March 2022
Seeking Alpha
Tuesday, 8 March 2022
GlobeNewsWire
Friday, 11 February 2022
Benzinga
Wednesday, 22 December 2021
InvestorPlace
Tuesday, 21 December 2021
Seeking Alpha
Monday, 20 December 2021
GlobeNewsWire
Friday, 12 November 2021
Seeking Alpha
Tuesday, 9 November 2021
Seeking Alpha
Wednesday, 3 November 2021
GlobeNewsWire
Monday, 1 November 2021
InvestorPlace
Friday, 29 October 2021
InvestorPlace
Wednesday, 29 September 2021
Zacks Investment Research
Thursday, 23 September 2021
GlobeNewsWire
Wednesday, 15 September 2021
GlobeNewsWire
Tuesday, 7 September 2021
GlobeNewsWire
Monday, 23 August 2021
InvestorPlace
  • When is Surgalign Holdings's next earnings date?

    Unfortunately, Surgalign Holdings's (SRGA) next earnings date is currently unknown.

  • Does Surgalign Holdings pay dividends?

    No, Surgalign Holdings does not pay dividends.

  • What is Surgalign Holdings's stock symbol?

    Surgalign Holdings, Inc. is traded on the NASDAQ under the ticker symbol "SRGA".

  • What is Surgalign Holdings's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Surgalign Holdings?

    Shares of Surgalign Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Surgalign Holdings's key executives?

    Surgalign Holdings's management team includes the following people:

    • Mr. Joshua H. DeRienzis Chief Legal Officer & Corporation Sec.(age: 56, pay: $833,520)
    • Mr. Terry M. Rich Pres, Chief Executive Officer & Director(age: 57, pay: $646,350)
    • Mr. William Scott Durall Chief Commercial Officer(age: 61, pay: $373,200)
  • How many employees does Surgalign Holdings have?

    As Jul 2024, Surgalign Holdings employs 217 workers.

  • When Surgalign Holdings went public?

    Surgalign Holdings, Inc. is publicly traded company for more then 25 years since IPO on 11 Aug 2000.

  • What is Surgalign Holdings's official website?

    The official website for Surgalign Holdings is surgalign.com.

  • Where are Surgalign Holdings's headquarters?

    Surgalign Holdings is headquartered at 520 Lake Cook Road, Deerfield, IL.

  • How can i contact Surgalign Holdings?

    Surgalign Holdings's mailing address is 520 Lake Cook Road, Deerfield, IL and company can be reached via phone at +224 3034651.

Surgalign Holdings company profile:

Surgalign Holdings, Inc.

surgalign.com
Exchange:

NASDAQ

Full time employees:

217

Industry:

Medical - Devices

Sector:

Healthcare

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

520 Lake Cook Road
Deerfield, IL 60015

CIK: 0001760173
ISIN: US86882C2044
CUSIP: 86882C204